Successful treatment of SUNCT syndrome with divalproex sodium extended-release
Headache Medicine · 2010
DOI: 10.48208/headachemed.2010.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache Medicine, 2010. Verfasst von Raimundo Pereira da Silva Neto und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) syndrome is a primary rare headache. This syndrome is known to be refractory to pharmacotherapy. Various treatments have been tried for SUNCT syndrome, generally of little benefit.
Objective
To report a case of SUNCT syndrome who was successfully treated with divalproex sodium extended-release (DVPX ER) and to review the literature about of drugs used in this treatment. Patient and Method: The authors report a case of a 61 year-old man, suffering from SUNCT syndrome, who was successfully treated with DVPX ER. We review the literature about several categories of drugs that are used in the treatment to this syndrome.
Conclusion
SUNCT syndrome is clinically well identified, but it is poorly treated. This is first report of SUNCT syndrome responsive to DVPX ER.
Zitieren
APA
Neto, R. P. D. S., & Almeida, K. J. (2010). Successful treatment of SUNCT syndrome with divalproex sodium extended-release. Headache Medicine. https://doi.org/10.48208/headachemed.2010.9
Vancouver
Neto RPDS, Almeida KJ. Successful treatment of SUNCT syndrome with divalproex sodium extended-release. Headache Medicine. 2010. doi:10.48208/headachemed.2010.9
BibTeX
@article{Neto2010,
author = {Neto, Raimundo Pereira da Silva and Almeida, Kelson James},
title = {Successful treatment of SUNCT syndrome with divalproex sodium extended-release},
journal = {Headache Medicine},
year = {2010},
doi = {10.48208/headachemed.2010.9}
}
EUVIMED